VERONA PHARMA PLC - ADR (VRNA) Stock Income Statement
NASDAQ:VRNA - Nasdaq - US9250501064 - ADR - Currency: USD
| TTM (2025-3-31) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 118.53M | 42.28M | 0.00 | 460.00K | 40.00M | |||
| Cost Of Goods | N/A | 2.58M | 0.00 | 350.00K | N/A | |||
| Gross Profit | N/A | 39.70M | 0.00 | 110.00K | N/A | |||
| Operating Expenses | 250.29M | 194.32M | 67.57M | 75.85M | 113.31M | |||
| Research and Development | 51.86M | 44.57M | 17.22M | 49.28M | 79.41M | |||
| Selling, General, and Administrative Expenses | 198.43M | 149.75M | 50.35M | 26.58M | 33.91M | |||
| Operating Income | -137.75M | -154.63M | -67.57M | -75.75M | -73.31M | |||
| Interest Income/Expense | -15.86M | -8.45M | 12.57M | -1.52M | 2.10M | |||
| Other Income/Expense | N/A | 3.60M | 1.10M | 9.63M | 15.63M | |||
| Non Recurring Items | -4.06M | -3.65M | 0.00 | -820.00K | N/A | |||
| Income Before Taxes | -154.65M | -163.13M | -53.90M | -68.45M | -55.59M | |||
| Income Tax | 9.30M | 10.29M | 474.00K | 250.00K | -20.00K | |||
| Net Income | -163.94M | -173.42M | -54.37M | -68.70M | -55.57M | |||
| EBITDA | -136.66M | -153.57M | -66.89M | -75.11M | -72.68M | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | -2.00 | -2.12 | -0.68 | -1.04 | -0.96 | |||
| Non GAAP EPS | -2.00 | -2.16 | -0.68 | -1.11 | -0.97 | |||
| Statistics | ||||||||
| Gross Profit Margin | N/A | 93.89% | N/A | 23.91% | N/A | |||
| Profit Margin | -138.31% | -410.18% | N/A | -14934.78% | -138.93% | |||
| Operating Profit Margin | -116.21% | -365.73% | N/A | -16467.39% | -183.28% | |||
All data in USD